UBS Maintains Buy on HCA Healthcare, Lowers Price Target to $579
Benzinga Newsdesk 3 months ago
NewsPrice TargetAnalyst Ratings
UBS analyst A.J. Rice maintains HCA Healthcare (NYSE:HCA) with a Buy and lowers the price target from $635 to $579.
UBS analyst A.J. Rice maintains HCA Healthcare (NYSE:HCA) with a Buy and lowers the price target from $635 to $579.